7 JCI-accredited hospitals · 45+ hospitals & clinics · 90+ countries served · 24/7 multilingual support
Prof. Yavuz Baykal, MD Internal Medicine · Acibadem Eskisehir Hospital

Prof. Yavuz Baykal, MD

✓ Medically verified profile
Internal Medicine · Acibadem Eskisehir Hospital

Prof. Yavuz Baykal, MD

Prof. Yavuz Baykal, MD is an Internal Medicine specialist at Acibadem Eskisehir Hospital in Eskişehir, Turkey. His subspecialty is Thyroid Diseases and Treatment, and his areas of expertise include thyroid diseases, thyroid disease treatment and obesity. He consults in Turkish and English, and video consultation is available for international patients before or after a hospital visit.

Medically verified profile 44+ years in medicineTurkish · EnglishVideo consultation available
Reach Dr. Baykal → Consultation options Free · a coordinator and the doctor’s team reply within 24 hours · no obligation
Prof. Yavuz Baykal, MDAccepting international patients
SpecialtyInternal Medicine
ConsultationVideo · In person · Second opinion
Profile

About Prof. Yavuz Baykal, MD

Prof. Yavuz Baykal, MD is an Internal Medicine specialist at Acibadem Eskisehir Hospital in Eskişehir, Turkey, where he works within the Internal Medicine unit. His subspecialty is Thyroid Diseases and Treatment, and his areas of expertise cover thyroid diseases, thyroid disease treatment and obesity. Dr. Baykal has more than 44 years in medicine and has been part of Acıbadem Healthcare Services since 2010.

He graduated from İstanbul University Cerrahpaşa Faculty of Medicine in 1982 and served as a Medical Lieutenant, completing Flight Medicine Training in 1982–1983 and then working at Gülhane Military Medical Academy from 1982 to 1990, where he undertook Internal Medicine Specialty Training between 1986 and 1990. From 1990 to 1993 he worked at Kütahya Hava Hospital. He returned to Gülhane Military Medical Academy as Assistant Associate Professor (1993–1996), became Associate Professor in 1996 and Professor in 2003, remaining there until 2007. From 2007 to 2010 he was Department Coordinator of Internal Medicine at Memorial Hospital. Dr. Baykal is a member of the İstanbul Medical Chamber and the Turkish Internal Medicine Association. His published research includes studies on the effects of statins and antihypertensive agents on oxidative stress, insulin resistance, diabetes and its complications, osteoporosis in postmenopausal women, and immunological markers in rheumatologic conditions such as Behçet’s disease and Familial Mediterranean Fever.

Clinical focus

Dr. Baykal’s clinical work centers on thyroid diseases and their treatment. Within Internal Medicine, thyroid disorders are assessed through a review of the patient’s history and symptoms, a clinical examination and existing laboratory and imaging findings, followed by a discussion of treatment options suited to the individual case. Treatment plans are reviewed over time, as thyroid conditions may need ongoing monitoring.

His second area of expertise is obesity. As an Internal Medicine specialist, he approaches obesity in the context of a patient’s overall health, taking into account related metabolic factors identified during assessment. Several of his publications address insulin resistance, serum lipid levels and body measurements in patients with diabetes, reflecting a long-standing interest in metabolic conditions.

How Dr. Baykal works with international patients

Dr. Baykal consults in Turkish and English, and interpreters can be arranged for patients who speak other languages. Before a visit, the Acibadem international patient team coordinates the collection of prior reports and imaging, such as ultrasound, CT or MRI reports, laboratory and pathology results, operative notes and discharge summaries, and arranges appointments and the hospital visit. A first consultation typically covers the patient’s history and symptoms, a review of existing imaging and previous treatments, a clinical examination and a discussion of the options. Video consultation is available for international patients who wish to discuss their situation before traveling or as a follow-up after a visit.

Clinical focus

What Dr. Baykal treats and performs

Each item opens the condition or treatment page with the care pathway for international patients.

Areas of practiceThyroid diseases and treatment

Conditions treated

Background

Education, career and memberships

Education & training

Education

  • 2003Gülhane Military Medical Academy / Professor
  • 1996Gülhane Military Medical Academy / Associate Professor
  • 1990Gülhane Military Medical Academy Department of Internal Medicine
  • 1982İstanbul University Cerrahpaşa Faculty of Medicine
Career

Professional Experience

  • 2010Acıbadem Healthcare Services
  • 2007–2010Memorial Hospital, Department Coordinator of Internal Medicine
  • 2003–2007Gülhane Military Medical Academy, Professor
  • 1996–2003Gülhane Military Medical Academy, Associate Professor
  • 1993–1996Gülhane Military Medical Academy, Assistant Associate Professor
  • 1990–1993Kütahya Hava Hospital
  • 1986–1990Gülhane Military Medical Academy, Internal Medicine Specialty Training
  • 1982–1990Gülhane Military Medical Academy, Medical Lieutenant
  • 1982–1983Flight Medicine Training, Medical Lieutenant
Memberships

Professional Memberships

  • İstanbul Medical Chamber
  • Turkish Internal Medicine Association
Selected publications

Selected Publications

  • Effects of statins on oxidative stress Biol Trace Elem Res. 2004 May; 98(2):119-27. MI. YILMAZ, Y. BAYKAL, M. KILIÇ, A. SÖNMEZ, F. BULUCU, A. AYDIN, A. SAYAL, IH. KOÇAR
  • Anti-annexin V autoantibody in thrombophlic Behçet’s disease Rheumatology Int. 24;77-79,2004 H. ASLAN, S. PAY, F. GÖK, Y. BAYKAL, MI. YILMAZ, A. ŞENGÜL, HI. AYDIN.
  • Effects of antihypertensive agents, alpha receptor blockers, beta blockers, ACE inhibitors, angiotensin receptor blockers, calcium channel blockers on oxidative stress J. Hypertension. 21(6);1207-1211;2003. Y. BAYKAL, MI. YILMAZ, T. ÇELİK, F. GÖK, H. REHBER, C. AKAY, İH. KOÇAR.
  • Fluvastatin improves insulin resistance in nondiabetic dyslipidemic patients . Endocrine. 2003 Nov;22(2):151-4. A. SÖNMEZ, Y. BAYKAL, MI. YILMAZ, M. KILIÇ, K. SAĞLAM, F. BULUCU, IH. KOÇAR
  • Serum sIL-2r, IL-6, IL-10 and TNFa in Familial Mediterranean Fever patient Rheumatology Int. 22; 99-101;2003. Y. BAYKAL, K. SAĞLAM, I.YILMAZ, A. TAŞLIPINAR, S.B. AKINCI, A. İNAL.
  • Insulin resistance in patients with steatohepatitis. Hepato-Gastroentorology. 50;456-459;2003 K.SAĞLAM, R KILIÇ, İ YILMAZ, M GÜLEÇ, Y BAYKAL, M KUTLU
  • Renal involvement in patient with idiopathic hypereosinophilic syndrome Clin Nephrol. 57(2);171-173;2002 F. BULUCU, C.CAN, V. İNAL, Y. BAYKAL, S. ERİKÇİ.
  • Hypersensitivity vasculitis and cytokines Rheumatology Int. 22;244-248:2002. S. NALBANT, B. KOÇ, C. TOP, Y. KÜÇÜKARDALI, Y. BAYKAL, M. DANACI, İ.H. KOÇAR
  • The levels of circulating intercellular adhesion molecule Rheumatology Int. 21;146-148;2002. K. SAĞLAM, I.YILMAZ, A. SAĞLAM, M. ÜLGEY, F. BULUCU, Y. BAYKAL
  • Effect of hyperinsulinemia on ADP- and collagen-stimulated platelet aggregation in hypertensive patients Trends in endocronology.1(9);18-25;2000 T. ÜNAL, H. YILMAZ, R. MAS, Y. BAYKAL, M. KUTLU, N. ÖZCAN, F. KOCABALKAN
  • The levels of free oxygen radicals and the antioxidant enzymes in the patients with Behcet’s disease EULAR 2000. SERÇE A, ASLAN H, SAĞLAM K, BAYKAL Y, KOCABALKAN F.
  • Renin angiotensin aldosterone system and drug allergies complicated with hypotension Asian Pacific J Allergy Immunology 18(2);81-83;2000. M. KARAAYVAZ, Z. ÇALIŞKANER, Y. BAYKAL, N. OZANGÜÇ
  • The relationship between the skinfold thickness and hormone levels in elderly diabetic male patients. Turkish Medical Journal 6(6);303-6;1999 Y. BAYKAL, A. YÖNEM, B. ÇAKIR, Z. ÇALIŞKANER, F. BULUCU, B. CÖMERT, F. KOCABALKAN
  • Mean platelet volume in diabetic patients and its relationship with metabolic control and complications Clinical Sciences, Doctor 5;(5);586-9;1999 YÖNEM, B. ÇAKIR, Y. BAYKAL, Ş. ÖZGÜMÜŞ, Ö. AZAL, F. KOCABALKAN
  • Cardiopulmonary resuscitation: A survey research on prejudices. GATA Bulletin 41(2):152-6;1999 Ç. ÖKTENLI, F. BULUCU, F. KOCABALKAN, A. SÖNMEZ, Y. BAYKAL
  • Serum levels of osteocalcin and type I procollagen in pre and postmenopausal women Turkish Medical Journal 6(2);102-4;1999 TARÇIN. O, BAYKAL.Y, YÖNEM. A, ÇAKIR. B, KOCABALKAN. F.
  • Hypertension prevalence among military students. Balkan Mılıtary Medıcal Revıew 1999; 2(2);136-138 MT. ÜNAL, M. TURAN, K. SAĞLAM, B. KOÇ, Y. BAYKAL, H. DORUK, F.KOCABALKAN.
  • The relationship between the skinfold thickness and hormone levels in elderly diabetic male patients Turkish Medical Journal 6(6);303-6;1999 Y. BAYKAL, A. YÖNEM, B. ÇAKIR, Z. ÇALIŞKANER, F. BULUCU, B. CÖMERT, F. KOCABALKAN.
  • The relationship between waist/hip ratio, skinfold thickness and serum lipid levels in type two diabetic male patients Turkish Medical Journal 6(4);222-5;1999 Y. BAYKAL, A. YÖNEM, B. ÇAKIR, B. CÖMERT, B. KOÇ, F. KOCABALKAN.
  • Interleukin 1 beta levels in patients with reactive arthritis Turkish Medical Journal 6(4);201-3;1999 Y. BAYKAL, A. YÖNEM, B. ÇAKIR, Z. ÇALIŞKANER, A. ŞENGÜL, K. SAĞLAM, T. ÜNAL, F. KOCABALKAN.
  • The relationship between skin thickness and skin collagen in post- and premenopausal women GATA Bulletin 40(2)169-71:1998 O.TARÇIN, Y.BAYKAL, M. SAĞLAM.
  • Toxoplasma infection in patients with systemic lupus erythematosus J.Rheumatol 1998;25 (10);2038-2039 Y. BAYKAL, K. SAĞLAM, Z. ÇALIŞKANER.
  • Association between syndactyly type II and hypertension. T Klin Med. Sci. 18(3):185-89:1998 G. ÖZET, Y. BAYKAL, Z. ÇALIŞKANER.
  • Comparison of ultrasound velocity measurement with DEXA in the assessment of osteoporosis in elderly women. Turkish Medical Journal. 5(5):296-99:1998 Y. BAYKAL, A. YÖNEM, O. TARÇIN, F. KOCABALKAN.
  • Hypertension prevalence among males aged between 20-30 Balkan Mılıtary Medıcal Revıew 1998; ID Number 40-41 MT. ÜNAL, K. SAĞLAM, Y. BAYKAL, M. TURAN, H. ÇALIŞ, F. KOCABALKAN
  • Parvovirus B19 antibodies in disease asociated with vasculitis Balkan Mılıtary Medıcal Revıew 1998;1(1):86-88. Y. BAYKAL, M. BAYSALLAR, M. KARAAYVAZ, B. KOÇ, G. ÖZET, MT. ÜNAL, F. KOCABALKAN
  • The effect of alendronate treatment on bone mineral density and biochemical markers in postmenopausal women . 5(6);382-4;1998 O. TARÇIN, Y. BAYKAL, B. KOÇ, Z. POLAT, T. ÜNAL, F. KOCABALKAN.
  • Insulin resistance in patients with steatohepatitis. Diabetes Yearbook 1998-1999;140-50 R. KILINÇ, K. SAĞLAM, F. BULUCU, Y. BAYKAL, M. KUTLU.
  • The relatıon of vascular complication to carotid intima media thickness in patient with NIDDM. . Turk J Med Res. 15;72-76:1997 M. ERCAN, F. KOCABALKAN, Z. ÇALIŞKANER, K. SAĞLAM, Y. BAYKAL.
  • The relation of arterial blood pressure and serum lipids to carotid-intima media thickness in patients with NIDDM Turk J Med Res 15;32-35;1997 F. KOCABALKAN, Y. BAYKAL, M. ERCAN, Z. ÇALIŞKANER, B. KOÇ, R. MAS.
  • The relation of age, sex, smoking, body mass index to carotid intima media thickness in patients with NIDDM Turk J Med Res. 15:77-80;1997 F. KOCABALKAN, M. ERCAN, Y. BAYKAL, Z. ÇALIŞKANER, R. MAS, K. SAĞLAM
  • The relationship between skin thickness and skin collagen content and bone mineral density in postmenopausal women. GATA Bulletin 39;519-25:1997 O. TARÇIN, F. KOCABALKAN, Y. BAYKAL, M. SAĞLAM, D. DEVECI, A. BEKTAŞ, Z. ÇALIŞKANER
  • Plasma thromboxane, prostacyclin levels and the effect of aspirin in patients with type II diabetes mellitus GATA Bulletin 39:472-5;1997 Y. BAYKAL, B. KOÇ, Z. ÇALIŞKANER, B. CÖMERT, T. ÜNAL, M. KUTLU, F. KOCABALKAN.
  • The evaluation of gallbladder motility before and after ESWL Endoscopy. 1996;4:161-3. MR. MAS, Ü. ATEŞKAN, A. DINC, S. NALBANT, Y. BAYKAL, B. KOÇ, F. KOCABALKAN.
  • Effect of dexfenfluramine on laboratory parameters. Turk J Med. Res. 1996; 14(3). Y. BAYKAL, I. YAVUZ, S. KÖMÜRCÜ, B. KOÇ, R. MAS, M. KUTLU, F. KOCABALKAN.
  • Effects of tamoxifen treatment on plasma lipids and lipoproteins in breast cancer patients Acta Ongologica Turcica 1996;28(1-2):8-10. Y. BAYKAL, S. KÖMÜRCÜ, G. ÖZET, A. ÖZET, F. ARPACI, H. YILMAZ, B. ÖZTÜRK, M. BEYZADEOĞLU.
  • Investigation of insulin resistance in hypertensive patients using hyperinsulinemic euglycemic glucose clamp technique Turkish Diabetes Yearbook. 1996-97;12:162-70. C. GÖNLÜŞEN, S. NALBANT, R. MAS, Y. BAYKAL, B. KOÇ, M. KUTLU
  • Insulin resistance in rheumatic diseases. Turkish Diabetes Yearbook. 1996-97;12:156-61. İ. YAVUZ, R. MAS, Y. BAYKAL, S. NALBANT, B. KOÇ, K. SAĞLAM, M. KUTLU
  • Effects of drugs used in the treatment of supraventricular tachycardia. Y. BAYKAL, B. KOÇ, O. ŞENER, G. ÖZET, T. ÜNAL, F. KOCABALKAN
  • Effect of oral cholestyramine on gallbladder motility in gallstone patients Endoscopy. 1996;4:151-3. MR. MAS, Ü. ATEŞKAN, A. DINC, S. NALBANT, Y. BAYKAL, B. KOÇ, F. KOCABALKAN
  • Lipoprotein (a) levels in hemodialysis patients with chronic renal failure. Y. BAYKAL, H. LEVENT, B. KOÇ, MR. MAS, K. SAĞLAM, T. ÜNAL, F. KOCABALKAN
  • As a risk factor the levels of cholesterol and triglyceride in the four age group of Turkish population Turk J. Med: Res. 1996 (2). F. KOCABALKAN, Y. BAYKAL, B. KOÇ.
  • The changes of plasma lipoproteins in patients with hepatitis Y. BAYKAL, B. KOÇ, G. ÖZET, R. MAS, M. SHALK, T. UNAL, F. KOCABALKAN
  • Effects of cilazapril on left ventricular parameters, serum ACE level and blood pressure in patients with essential hypertension T. Klin. J. Cardiol, 1996;(9):101-4. E.SARAÇOĞLU, N.ÖZCAN, Y.BAYKAL, K.SAĞLAM, F.KOCABALKAN.
  • Soluble CD44 levels in Behçet’s disease GATA Bulletin, 1996;38:4-8. B. KOÇ, R. ÖZTÜRK, Y. BAYKAL, M. KUTLU, R. MAS, K. SAĞLAM, F. KOCABALKAN.
  • Superoxide dismutase and glutathione peroxidase in Behçet’s disease. T.Klin.Medicine Bulletin. 1996 (16):170-73. Y. BAYKAL, A. BATTAL, Ş. KÖMÜRCÜ, Ç. ÖZDEMİR, T. ÜNAL, F. KOCABALKAN
  • Evaluation of cellular immunity in atopic patients during pollen season and off-season Turkish Medical Journal.1996 M. KARAAYVAZ, O. ŞENER, A. ŞENGÜL, Y. BAYKAL, B. KOÇ, N. OZANGÜÇ.
  • HBsAg incidence in ischemic heart disease patients. Tur. J. Med: Res. 1996; 14(1):35. Y. BAYKAL, C. ERDÖL, F. KOCABALKAN.
  • Investigation of renal involvement in patients with multiple myoloma GATA Bulletin. 1996;38:300-3. A.UYGUN, S. ERİKÇİ, M. YENİCESU, A. VURAL, Y. BAYKAL, A. KUBAR, B. CELASUN.
  • Association between ischemic heart disease and ABO blood groups. TCDD Hospital Bulletin. 1996;(1-2): 38-42. Y. BAYKAL, B. KOÇ, O. ŞENER, R. MAS, S. PAY, T. ÜNAL, F. KOCABALKAN
  • Antibodies against HCV in hemodialysis patients T.J. Gastroenterology, 1996; 7(4):293-4. MR. MAS, S. NALBANT,Y. BAYKAL, Ü. ATEŞKAN, A. DINÇ, T. UNAL, F. KOCABALKAN.
  • Effects of Hydroxyzine and Terfenadine on skin tests with allergens and histamine A.Ü.T.F. Journal. 1996, 49(2):81-86. M. KARAAYVAZ, Y. BAYKAL, V. KÖSEOĞLU, N. OZANGÜÇ,
  • Synovial fluid characteristics in patients with Behcet’s disease GATA Bulletin, 1996;38:342-46. B. KOÇ, Y. BAYKAL, R. MAS, B. TOY, B. CÖMERT, T. ÜNAL, F. KOCABALKAN
  • Serum complement and immunoglobulin levels in patients with chronic liver disease Journal of Endoscopy. 1996;2:87-93. Y. BAYKAL, M.R. MAS, B. KOÇ, K. SAĞLAM, S. PAY, T. ÜNAL, F. KOCABALKAN
  • Effect of Erythromycin on gallbladder function in diabetic patients with autonomic neuropathy Endoscopy Journal, 1996;2:80-82. Ü. ATEŞKAN, R. MAS, A. DİNÇ, Y. BAYKAL, S. ERİKÇİ, T. ÜNAL, F. KOCABALKAN
  • Effect of dexfenfuramine on obesity Turk J. Med. Res. 1996 14(3). Y. BAYKAL, B. KOÇ, I. YAVUZ, S. KÖMÜRCÜ, T. ÜNAL, M. KUTLU, F. KOCABALKAN.
  • Effect of antiasthmatic drugs on skin tests with allergens and histamine GATA Bulletin, 1996;(38):149-53. M. KARAAYVAZ, B. KOÇ, Y. BAYKAL, V. KÖSEOĞLU, N. OZANGÜÇ
  • The levels of ICAM-1 in Behçet’s disease Turkish J. Med. Res. 1995;13(4):136-138. K. SAĞLAM, Y. BAYKAL, M. ÜLGEY, Ç. ÖZDEMIR, S. ERİKÇİ, F. KOCABALKAN
  • Serum cholesterol levels in suicide attempters. T. Klin. Medical Sciences. 1995;15:351-53 Y. BAYKAL, S. PAY, K. SAĞLAM, B. KOÇ, S. ERİKÇİ, Z. ÇALIŞKANER, F. KOCABALKAN
  • Evaluation of left ventricular function in asymptomatic diabetic patients with heart disease using MUGA T.Diabet Yearbook 1995-1996;11:198-204. A. YÖNEM, K. SAĞLAM, M. KUTLU, Y. BAYKAL, R. MAS, B. KOÇ, F. KOCABALKAN
  • Soluble interleukin-2 receptor levels in patients with Behçet’s disease Turkish J. Med. Res. 1995; 13(5):195-97. B. KOÇ, Y. BAYKAL, S. KÖMÜRCÜ, S. ERİKÇİ, M. KUTLU, F. KOCABALKAN
  • Determination of serum apolipoprotein A-1 and apoprotein B-100 levels in young male patients with acute myocardial infarction Türk J. Gastroenterol,1995;6:175-77. F. ÇİÇEKÇİBAŞI, S. ERİKÇİ, B. KOÇ, Y. BAYKAL, K. SAĞLAM, F. KOCABALKAN.
  • Association of selenium and glutathione peroxidase activity levels with ischemic heart disease GATA Bulletin, 1995;37:58-62. K. SAĞLAM, S. ERİKÇİ, F. KOCABALKAN, R. MAS, Y. BAYKAL, E. IŞIMER
  • The relationship between cancer and age groups. TCDD Hospital Medical Bulletin. 1995:(2):35-39. F. KOCABALKAN, Y. BAYKAL, A. ÖZET, B. KOÇ, Ş. KÖMÜRCÜ, T. ÜNAL, R. MAS, S. ERİKÇİ.
  • Tumor necrosis factor a in peripheral blood and coronary sinus blood in coronary artery disease MN Cardiology 1995;2:124-29. F. AVCI, I.H. KOÇAR, A. BARUT, A. YÖNEM, H. TATAR, F. KOCABALKAN, Y. BAYKAL, K. SAĞLAM.
  • Antiphospholipid antibodies in acute joint rheumatism with and without carditis GATA Bulletin, 1995;38:235-39. T. ÇETIN, K. SAĞLAM, I.H. KOÇAR, T. ÜNAL, Y. BAYKAL, F. KOCABALKAN,
  • Effect of ketotifen on allergy skin tests. T.Klin. Med. Bilim. 1995;15:241-43. M. KARAAYVAZ, V. KÖSEOĞLU, Y. BAYKAL, A. ŞENGÜL, N. OZANGÜÇ.
  • Factors precipitating diabetic ketoacidosis GATA Medical Bulletin 1995;37:466-69. F. KOCABALKAN, K. SAĞLAM, R. MAS, Ü. ATEŞKAN, Y. BAYKAL, C. TOP, M. KUTLU.
  • Association of free radical scavenging enzyme superoxide dismutase and serum copper, zinc and selenium levels with chronic complications of diabetes. GATA Bulletin, 1995;37:218-22. A. BATTAL, Y. BAYKAL, S. ERİKÇİ, K. SAĞLAM, T. ÜNAL, F. KOCABALKAN.
  • The effect of nisoldipine on platelet aggregation Turk. J. Med. Res. 1995; 13(5):174-76. YALÇIN, A.U. URAL, Y. BAYKAL, C. BEYAN, I. YAVUZ, T. ÇETIN.
  • ESWL results in 31 patients with symptomatic cholelithiasis Gastroenterology; 1994; 5(3):418-20. MR. MAS, A. DINÇ, S. ERİKÇİ, Ü. ATEŞKAN, K. SAĞLAM, Y. BAYKAL, T. ÜNAL, F. KOCABALKAN.
  • Serum ferritin, serum iron levels in patients with acute chronic hepatitis and cirrhosis GATA Bulletin: 1994;36:33-39. E. ABAYLI, S. ERİKÇİ, Y. BAYKAL, T. ÜNAL, K. SAĞLAM, Ç. ÇETINEL, F. KOCABALKAN,
  • Antiphospholipid antibody levels in Behçet’s disease GATA Medical Bulletin: 1994;36:467-70. B. KOÇ, Ç. ÖZDEMIR, S. ERİKÇİ, H. GÜN, T. ÜNAL, Y. BAYKAL, K. SAĞLAM, F. KOCABALKAN.
  • The effect of serum magnesium deficiency on platelet aggregation in patients with type II D.M. GATA Bulletin: 1994;36:495-97. B. KOÇ, Ç. ÖZDEMİR, F. KOCABALKAN, Z. BEYHAN, C. BEYAN, K. SAĞLAM, Y. BAYKAL.
  • Prevalence of hemochromatosis in healthy young men and the role of transferrin saturation in the diagnosis of hemachromatosis Journal of Optimal Medicine: 1994; 7(4):146-52. S. ÖZAYDIN, S. ERİKÇİ, F. KOCABALKAN, G. YILDIRIM, Y. BAYKAL, K. SAĞLAM
  • Association of oral candidiasis with diabetic control, oral prosthesis and T lymphocyte functions in patients with type II diabetes mellitus GATA Bulletin: 1991;33:527-32. Y. BAYKAL, Ç. ÖZDEMİR, T. ÜNAL, F. ARPACI, S. ERİKÇİ, M. KUTLU, H. SAYAR
  • Serum cholesterol and triglyceride levels in patients with gastric and colon cancer GATA Bulletin; 1990;32:769-73. Ç. ÖZDEMIR, A. YALÇIN, M. KUTLU, S. ERİKÇİ, F. ARPACI, Y. BAYKAL.
Good to Know

Frequently Asked Questions

Which conditions does Dr. Baykal treat?
Dr. Baykal is an Internal Medicine specialist whose subspecialty is Thyroid Diseases and Treatment. His areas of expertise include thyroid diseases, thyroid disease treatment and obesity. Patients are assessed within the Internal Medicine unit, and treatment options are discussed on the basis of the individual history, examination findings and existing test results.
Where does Dr. Baykal see patients?
Dr. Baykal practices at Acibadem Eskisehir Hospital in Eskişehir, Turkey, within the Internal Medicine unit. He has been part of Acıbadem Healthcare Services since 2010. The international patient team arranges appointments and organizes the hospital visit for patients traveling from abroad.
Which languages does Dr. Baykal speak?
Dr. Baykal consults in Turkish and English. For international patients who speak other languages, interpreters can be arranged through the international patient team so that the consultation, examination findings and discussion of options can be followed clearly.
What should I send before a case review with Dr. Baykal?
It is helpful to provide prior medical reports and imaging, such as ultrasound, CT or MRI reports, laboratory and pathology results, operative notes and discharge summaries. The international patient team coordinates the collection of these documents so that existing findings and previous treatments can be reviewed before the consultation.
What is Dr. Baykal's training and academic background?
Dr. Baykal graduated from İstanbul University Cerrahpaşa Faculty of Medicine in 1982 and completed Internal Medicine Specialty Training at Gülhane Military Medical Academy in 1990, where he later served as Assistant Associate Professor, Associate Professor and Professor. He is a member of the İstanbul Medical Chamber and the Turkish Internal Medicine Association.
Can I have a video consultation with Dr. Baykal?
Yes, video consultation is available for international patients. It can be used to discuss symptoms, history and existing reports before traveling, or as a follow-up after a hospital visit. A clinical examination and any required tests are carried out in person at Acibadem Eskisehir Hospital.
Where

Hospitals

Departments

Medical Units

Treatments

Treatment guides

We’re With You at Every Step

How can we help you today?

We value your privacy We use essential cookies to run this site and, with your consent, analytics cookies to understand how it is used and improve it. You can accept, reject, or choose what to allow. See our Cookie Policy.